US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Oncotelic Therapeutics, Inc.

0.0465

-0.0005-1.17%

Volume:39.91K

Turnover:1.92K

Market Cap:20.53M

PE:- -

High:0.0500

Open:0.0500

Low:0.0465

Close:0.0471

52wk High:0.1100

52wk Low:0.0150

Shares:441.58M

Float Shares:214.45M

Volume Ratio:0.10

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

ROE:-23.72%

ROA:-1.57%

PB:2.27

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Oncotelic Therapeutics, Inc.

Exchange:

OTCQB

Establishment Date:

- -

Employees:

26

Office Location:

29397 Agoura Road,Suite 107,Agoura Hills,California,United States

Website:

http://www.mateon.com

Zip Code:

91301

Phone:

Fax:

650 635 7001

Introduction:

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma; intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson's Disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of Artemisinin based products and support technologies. Oncotelic Therapeutics, Inc. is based in Agoura Hills, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OTLC/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OTLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OTLC\",,,,,undefined,":{"symbol":"OTLC","market":"US","secType":"STK","nameCN":"Oncotelic Therapeutics, Inc.","latestPrice":0.0465,"timestamp":1771621200000,"preClose":0.04705,"halted":0,"volume":39914,"delay":15,"changeRate":-0.011689691817215768,"floatShares":214445090,"shares":441577283,"eps":0,"marketStatus":"Pre-Mkt","change":-0.00055,"latestTime":"02-20 16:00:00 EST Delay","open":0.05,"high":0.05,"low":0.0465,"amount":1921.4,"amplitude":0.074389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"exchange":"OTCQB","adjPreClose":0.0465,"volumeRatio":0.09569412401434804},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OTLC\",,,,,undefined,":{"symbol":"OTLC","floatShares":214445090,"roa":"-1.57%","roe":"-23.72%","lyrEps":0,"volumeRatio":0.09569412401434804,"shares":441577283,"dividePrice":0,"high":0.05,"amplitude":0.074389,"preClose":0.04705,"low":0.0465,"week52Low":0.015,"pbRate":"2.27","week52High":0.11,"institutionHeld":0,"latestPrice":0.0465,"eps":0,"divideRate":0,"volume":39914,"delay":15,"open":0.05,"prevYearClose":0.0784,"prevWeekClose":0.0465,"prevMonthClose":0.0772,"prevQuarterClose":0.0784,"fiveDayClose":0.049,"twentyDayClose":0.0765,"sixtyDayClose":0.0935},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OTLC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-12","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1712894400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"OTLC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OTLC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OTLC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":325153400,"employeeNum":26,"address":"29397 Agoura Road,Suite 107,Agoura Hills,California,United States","zipCode":"91301","officePhone":"650 635 7000","officeFax":"650 635 7001"},"stockCompanyDetail":{"websiteUrl":"http://www.mateon.com","description":"Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; and CA4P for the treatment of advanced metastatic melanoma; intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson's Disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of Artemisinin based products and support technologies. Oncotelic Therapeutics, Inc. is based in Agoura Hills, California.","exchange":"OTCQB","name":"Oncotelic Therapeutics, Inc.","nameEN":"Oncotelic Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OTLC\",market:\"US\",,,undefined,":null}}